Skip to main content
logo
AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
10.97
+0.61 (5.89%)
At close: Aug 13, 2026, 4:00 PM EDT
10.96
-0.01 (-0.09%)
After-hours: Aug 13, 2026, 7:59 PM EDT

AbCellera Biologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-164.66-146.41-162.86-146.4158.52153.46
Depreciation & Amortization
32.5928.829730.8933.117.25
Stock-Based Compensation
51.155.7967.5864.1849.4830.65
Other Adjustments
8.221.2-84.44-5.786.431.55
Change in Receivables
-17.73-55.62-75.12-45.93106.4622.48
Changes in Accounts Payable
-5.813.4610.64-15.1-2.09-3.24
Changes in Income Taxes Payable
-37.87-29.846.6530.46-88.61-13.53
Changes in Unearned Revenue
26.16-5.8326.0425.5515.4539.34
Changes in Other Operating Activities
5.5417.155.9518.25-1.38-3.38
Operating Cash Flow
-94.94-131.3-108.56-43.88277.36244.58
Operating Cash Flow Growth
----13.40%977.94%
Capital Expenditures
-24.73-42.77-78.4-76.95-70.66-58.45
Purchases of Intangible Assets
-----2-
Purchases of Investments
-459.82-443.18-784.71-1,035-789.66-305.03
Proceeds from Sale of Investments
496.19506.07937.88910.94510.6327.61
Cash Acquisitions
------11.46
Other Investing Activities
81.8267.6346.64-19.9-0.9415.09
Investing Cash Flow
97.8987.75121.41-221.11-352.63-332.25
Other Financing Activities
27.6714.0812.7710.36-1.63-3.89
Financing Cash Flow
25.0714.0812.7710.36-1.63-3.89
Foreign Exchange Rate Adjustments
-0.721.1-2.620.59-9.6-1.43
Net Cash Flow
27.3-28.3723.01-254.04-86.49-92.97
Free Cash Flow
-119.67-174.07-186.95-120.82206.7186.13
Free Cash Flow Growth
----11.05%1329.91%
FCF Margin
-180.85%-231.69%-648.40%-317.75%42.58%49.61%
Free Cash Flow Per Share
-0.40-0.58-0.64-0.420.660.58
Levered Free Cash Flow
-168.77-175.43-94.98-133.2944.33131.46
Unlevered Free Cash Flow
-192.53-208-187.93-186.4429.35121.14
SEC Filings: 10-K · 10-Q